Market Tracker

02/10 12:50pm ET

Arbutus Biopharma Corp (NASDAQ:ABUS)

2.97
BATS BZX Real-Time Price
As of 12:48pm ET
 -0.03 / -1.00%
Today’s Change
2.72
Today|||52-Week Range
23.35
-33.26%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close3.00
Today’s open3.02
Day’s range2.91 - 3.07
Volume84,796
Average volume (3 months)318,959
Market cap$163.7M
Dividend yield--
Data as of 12:48pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-95.65%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-3.31%
P/E ratio--
Price/Sales22.17
Price/Book0.76

Competitors

 Today’s
change
Today’s
% change
AGRXAgile Therapeutics I...+0.15+2.55%
IMDZImmune Design Corp+0.51+6.29%
TTPHTetraphase Pharmaceu...+0.12+2.65%
CYNACynapsus Therapeutic...-0.04-0.30%
Data as of 12:35pm ET, 02/10/2016

Financials

Next reporting dateMarch 16, 2016
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$15.0M
Annual profit (last year)-$38.8M
Net profit margin-259.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Operating &
Business Officer
Patrick T. Higgins
Corporate headquarters
Burnaby, British Columbia

Forecasts